18 April 2019: Global Separation Systems for Commercial Biotechnology Market size is expected to reach USD 39.47 billion by 2025. The separation systems in biotechnology are also termed as “bioseparation systems”. Bio separation systems are used for the purification and separation of biological products such as biopharmaceuticals, biochemicals and diagnostic reagents depending upon electrostatic charge, density, diffusivity, shape, polarity, solubility, and volatility characteristics. The equipment’s used for the separation of biological material from complex mixture or solution include chromatography, membrane/ filters, and centrifuges. The separation systems for commercial biotechnology industry is expected to grow at the highest CAGR over the forecast period as the scope, product types, and its applications are increasing across the world.
The factors that play an important role in the growth of separation systems for commercial biotechnology market include increasing demand for novel drug molecules & cell-based therapies, booming biopharmaceutical & biotech firms, technological advancements in biotechnology sector, and stringent government rules & regulations. However, high cost of bio separation equipment’s and strict regulations regarding bioseparation systems are negatively affecting the growth of the market. The separation systems for commercial biotechnology industry is categorized based on method, application and geography.
Request Free Sample Copy of this Market Research @
Methods that could be explored in separation systems for commercial biotechnology market include conventional methods and modern methods. The conventional methods are classified into flow cytometry, chromatography, membrane filtration, centrifugation, electrophoresis, and others while the “modern methods” is segmented into lab-on-a-chip, microarray, biochip, magnetic separation and others. Conventional methods are expected to hold the largest market share in the forthcoming years. High investment by industrial key players for innovation of enhanced techniques such as membrane filtration and flow cytometry systems are factors driving the growth of conventional methods in the future period. However, modern methods are anticipated to grow at fastest pace in the years to come due to rising adoption of enhanced technology and increasing ongoing inventions in the biotechnology field.
Applications such as pharmaceutical, agriculture, food & cosmetics, energy, life sciences research and others could be explored in separation systems for commercial biotechnology industry in the coming years. Pharmaceutical is expected to be the largest application due to rising demand for biotherapies and ongoing inventions in the field of novel drug molecules.
North America is expected to be the top market for separation systems for commercial biotechnology in the future period. The presence of key manufacturers, growing technological advancements, and continuous R&D are anticipated to drive the market in this region in upcoming period. The U.S. represents the largest market for bioseparation systems in North America, followed by Canada. Further Europe and the Asia Pacific follow the market.
Browse Full Research Report with [email protected]
On the other hand, the Asia Pacific’s market is projected to hold higher share in the separation systems for commercial biotechnology market in forecast period. As increasing R&D expenditure and government initiative for the development of separation system in emerging countries such as India & China. Also, shortage of vaccines across the world, high demand for therapeutics, and ongoing research in the biotechnology field are expected to boost the market growth in this region.
The key players operating in the separation systems for commercial biotechnology industry are Shimadzu Corporation, MiltenyiBiotec, PerkinElmerInc., GE Healthcare, Agilent Technologies, Bio-Rad LaboratoriesInc., Thermo Fisher Scientific, Merck & Co.Inc., bioMérieux SA, Hitachi Koki Co.Ltd., WATERS, Sartorius, QIAGEN, Danaher and BD. These market players strongly invest in the expansion of their business and development of new biotechnologies system to maintain a top position in the market. Also, these players concentrating on new joint ventures, collaborations, agreements, and strategies to improve their production facilities and gain a larger share in the market.
Method Outlook (Revenue, USD Million; 2014 – 2025)
• Modern methods
• Magnetic separation
• Conventional methods
• Flow cytometry
• Membrane filtration
Application Outlook (Revenue, USD Million; 2014 – 2025)
• Human Blood Plasma Fractionation
• Mammalian Cell Cultures
• Food & Cosmetics
Regional Outlook (Revenue, USD Million; 2014 – 2025)
• North America
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)
• South Africa
See More Reports of this Category by Million Insights @ https://www.millioninsights.com/industry/biotechnology
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Office No. 302, 3rd Floor, Manikchand Galleria,
Model Colony, Shivaji Nagar, Pune, Maharashtra, 411016 India
Email: [email protected]